Of course not. All i am saying is that is what the cash component alone is worth. Quite high compared to most biotechs. The value of the stock will need to reflect values assigned to their various pipeline drugs on top of that.
- Forums
- ASX - By Stock
- BNO
- 40M + 10M = 50M = 47c per share
40M + 10M = 50M = 47c per share, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter